Narayan Nair

2.1k total citations · 2 hit papers
17 papers, 843 citations indexed

About

Narayan Nair is a scholar working on Infectious Diseases, Health and Surgery. According to data from OpenAlex, Narayan Nair has authored 17 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Health and 4 papers in Surgery. Recurrent topics in Narayan Nair's work include Vaccine Coverage and Hesitancy (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Narayan Nair is often cited by papers focused on Vaccine Coverage and Hesitancy (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Narayan Nair collaborates with scholars based in United States, Uganda and India. Narayan Nair's co-authors include Tom T. Shimabukuro, Paige Marquez, John R. Su, Jane Baumblatt, Kerry J. Welsh, Julianne Gee, Tanya R. Myers, Bicheng Zhang, Stacey W. Martin and Nicole P. Lindsey and has published in prestigious journals such as JAMA, PEDIATRICS and Obstetrics and Gynecology.

In The Last Decade

Narayan Nair

17 papers receiving 824 citations

Hit Papers

First Month of COVID-19 Vaccine Safety Monitoring — Unite... 2021 2026 2022 2024 2021 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narayan Nair United States 9 493 239 239 124 95 17 843
Charles Licata United States 5 397 0.8× 144 0.6× 230 1.0× 52 0.4× 28 0.3× 6 535
Reut Ohana Israel 4 481 1.0× 181 0.8× 141 0.6× 87 0.7× 15 0.2× 6 712
Gilbert T. Chua Hong Kong 14 287 0.6× 87 0.4× 62 0.3× 63 0.5× 20 0.2× 52 676
Erin Amerson United States 12 283 0.6× 145 0.6× 30 0.1× 36 0.3× 171 1.8× 42 841
Güliz Erdem United States 16 249 0.5× 195 0.8× 23 0.1× 31 0.3× 30 0.3× 82 843
Monique Landry Canada 14 140 0.3× 29 0.1× 198 0.8× 48 0.4× 26 0.3× 35 528
Elizabeth Phillips United States 5 244 0.5× 46 0.2× 55 0.2× 15 0.1× 158 1.7× 16 490
Zeinab Mohseni Afshar Iran 15 212 0.4× 68 0.3× 46 0.2× 92 0.7× 22 0.2× 58 509
Dwayne A. Wolf United States 15 259 0.5× 132 0.6× 24 0.1× 146 1.2× 8 0.1× 51 911
Agostino Nocerino Italy 10 302 0.6× 119 0.5× 20 0.1× 107 0.9× 9 0.1× 17 606

Countries citing papers authored by Narayan Nair

Since Specialization
Citations

This map shows the geographic impact of Narayan Nair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narayan Nair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narayan Nair more than expected).

Fields of papers citing papers by Narayan Nair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narayan Nair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narayan Nair. The network helps show where Narayan Nair may publish in the future.

Co-authorship network of co-authors of Narayan Nair

This figure shows the co-authorship network connecting the top 25 collaborators of Narayan Nair. A scholar is included among the top collaborators of Narayan Nair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narayan Nair. Narayan Nair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Moro, Pedro L., Paige Marquez, Naomi K. Tepper, et al.. (2025). Safety monitoring of Pfizer's Respiratory Syncytial Virus Vaccine in pregnant women in the Vaccine Adverse Event Reporting System (VAERS), 2023–2024, United States. Vaccine. 62. 127497–127497. 3 indexed citations
2.
Yih, W. Katherine, Jonathan Duffy, John R. Su, et al.. (2024). Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalink. American Journal of Otolaryngology. 45(6). 104448–104448. 1 indexed citations
3.
Marquez, Paige, Phillip G. Blanc, Kerry J. Welsh, et al.. (2024). Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). Drug Safety. 48(3). 279–286. 2 indexed citations
4.
Moro, Pedro L., Katherine E. Fleming-Dutra, Elisha Hall, et al.. (2024). Administration of the GSK Respiratory Syncytial Virus Vaccine to Pregnant Persons in Error. Obstetrics and Gynecology. 143(5). 704–706. 1 indexed citations
5.
Moro, Pedro L., et al.. (2023). Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023. MMWR Morbidity and Mortality Weekly Report. 72(31). 850–851. 2 indexed citations
6.
Abara, Winston E., Julianne Gee, Paige Marquez, et al.. (2023). Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States. JAMA Network Open. 6(2). e2253845–e2253845. 41 indexed citations
7.
Menschik, David, Deborah Thompson, Christopher Jankosky, et al.. (2023). Reporting rates for VAERS death reports following COVID ‐19 vaccination, December 14, 2020–November 17, 2021. Pharmacoepidemiology and Drug Safety. 32(7). 763–772. 1 indexed citations
8.
Hesse, Elisabeth M., Anne M. Hause, Tanya R. Myers, et al.. (2023). COVID-19 Vaccine Safety First Year Findings in Adolescents. PEDIATRICS. 151(5). 8 indexed citations
9.
Woo, Emily Jane, et al.. (2022). Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System. Pharmacoepidemiology and Drug Safety. 31(11). 1174–1181. 6 indexed citations
11.
Gee, Julianne, Paige Marquez, John R. Su, et al.. (2021). First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021. MMWR Morbidity and Mortality Weekly Report. 70(8). 283–288. 275 indexed citations breakdown →
12.
Shimabukuro, Tom T. & Narayan Nair. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine. JAMA. 325(8). 780–780. 227 indexed citations breakdown →
13.
Woo, Emily Jane, Adamma Mba‐Jonas, Rositsa B. Dimova, et al.. (2021). Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021. JAMA. 326(16). 1606–1606. 80 indexed citations
14.
Hesse, Elisabeth M., Beth F. Hibbs, Carmen S. Ng, et al.. (2019). Shoulder Injury Related to Vaccine Administration (SIRVA): Petitioner claims to the National Vaccine Injury Compensation Program, 2010–2016. Vaccine. 38(5). 1076–1083. 46 indexed citations
15.
Meissner, H. Cody, Narayan Nair, & Stanley A. Plotkin. (2019). The National Vaccine Injury Compensation Program. JAMA. 321(4). 343–343. 13 indexed citations
17.
Zhang, Liying, Narayan Nair, James W. Jennings, & Steven L. Bryant. (2005). Models and Methods for Determining Transport Properties of Touching-Vug Carbonates. Proceedings of SPE Annual Technical Conference and Exhibition. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026